Asperger syndrome future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 5: Line 5:


== Overview ==
== Overview ==
There have been some experimental therapy and suggestions such as [[oxytocin]] and treatment with stem cells in patients with Asperger Syndrome (AS).<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905  }} </ref>
There have been some experimental therapy and suggestions such as [[oxytocin]] and treatment with [[Stem cell|stem cells]] in patients with Asperger Syndrome (AS).<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905  }} </ref>


== Future or Investigational Therapies ==
== Future or Investigational Therapies ==

Latest revision as of 17:46, 22 June 2020

Asperger Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asperger Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asperger syndrome future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asperger syndrome future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asperger syndrome future or investigational therapies

CDC on Asperger syndrome future or investigational therapies

Asperger syndrome future or investigational therapies in the news

Blogs on Asperger syndrome future or investigational therapies

Directions to Hospitals TreatingAsperger syndrome

Risk calculators and risk factors for Asperger syndrome future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

There have been some experimental therapy and suggestions such as oxytocin and treatment with stem cells in patients with Asperger Syndrome (AS).[1]

Future or Investigational Therapies

Experimental therapy for Asperger Syndrome (AS) include:[1]

Oxytocin

  • Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytocin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).[2]
  • In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.[3]  

Stem cells  

  • Treatment of AS and ASD with stem cells is in the early stages.[1]

References

  1. 1.0 1.1 1.2 Tarazi FI, Sahli ZT, Pleskow J, Mousa SA (2015). "Asperger's syndrome: diagnosis, comorbidity and therapy". Expert Rev Neurother. 15 (3): 281–93. doi:10.1586/14737175.2015.1009898. PMID 25655905.
  2. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR; et al. (2003). "Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders". Neuropsychopharmacology. 28 (1): 193–8. doi:10.1038/sj.npp.1300021. PMID 12496956.
  3. Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010). "Promoting social behavior with oxytocin in high-functioning autism spectrum disorders". Proc Natl Acad Sci U S A. 107 (9): 4389–94. doi:10.1073/pnas.0910249107. PMC 2840168. PMID 20160081.